• Nenhum resultado encontrado

Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors

N/A
N/A
Protected

Academic year: 2021

Share "Visceral Obesity and Metabolic Syndrome Are Associated with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors"

Copied!
12
0
0

Texto

Loading

Imagem

Table 1. Demographic, anthropometric, clinical, and biochemical features of patients with WD GEP-NETs and controls.
Table 3. WD GEP-NETs patient characteristics.
Table 4. Association of MetS, MetS components, and IR with WD GEP-NETs and controls.

Referências

Documentos relacionados

O objetivo principal deste trabalho de dissertação passava por evoluir a versão do protótipo experimental FEUP-SBT-1.0, na qual é possível gerar o código de teste JUnit a partir

Prevalence of metabolic syndrome and associated cardiovascular risk factors in Guatemalan school children... Role of a critical visceral adipose tissue threshold (CVATT) in

Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). Weiss R, Dziura J, Burgert TS, Tamborlane

Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). Srinivasan SR, Myers L,

Obesity grade III; primary and/or secondary SAH, due to possible apnea/hypopnea syndrome; type II diabetes mellitus; metabolic syndrome; subclinical hypothyroidism;

Metabolic syndrome (MS) is a complex disorder represented by a cluster of cardiovascular risk factors related to central fat distribution and insulin resistance (IR), and

Chronic diseases such as obesity, type-2 diabetes, metabolic syndrome and cardiovascular diseases are associated with inflammation due the increase of TNF- α , IL-6

Três desfolhantes foram utilizados nas investigações em 1982: merphos por pulverização aérea, MSMA por pulverização aérea e terrestre, e thidiazuron através de